Status:
COMPLETED
Induction of Labor in Term Pregnancies With Unfavourable Cervix
Lead Sponsor:
Clinical Hospital Merkur
Conditions:
Induction of Labor Affected Fetus / Newborn
Prostaglandins Causing Adverse Effects in Therapeutic Use
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
This is a prospective randomized trial comparing two prostaglandin E2 (dinoprostone) agents used for labor induction in pregnant women with term pregnancies and unfavorable cervix.
Detailed Description
This prospective randomized trial includes pregnant women with term pregnancies, indication for labor induction and an unfavorable cervix. These women are randomized into two groups: one group is indu...
Eligibility Criteria
Inclusion
- term pregnancies (\> 37 weeks gestation)
- unfavourable cervix (Bishop score \<6)
- indication for labor induction
- absence of uterine contractions
- reassuring cardiotocography
Exclusion
- ruptured membranes
- scar uterus (previous caesarean section or uterus surgery)
- pregnancy complications: intrauterine growth restriction; oligohydramnios, pre-eclampsia, non-reassuring/pathological cardiotocography, cholestasis in pregnancy, diabetes mellitus, multifetal pregnancy, breech presentation
Key Trial Info
Start Date :
December 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT04280874
Start Date
December 10 2018
End Date
July 1 2020
Last Update
July 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Hospital Merkur
Zagreb, Croatia, 1000